[HTML][HTML] Polymer-and lipid-based nanocarriers for ocular drug delivery: Current status and future perspectives
H Han, S Li, M Xu, Y Zhong, W Fan, J Xu, T Zhou… - Advanced Drug Delivery …, 2023 - Elsevier
Ocular diseases seriously affect patients' vision and life quality, with a global morbidity of
over 43 million blindness. However, efficient drug delivery to treat ocular diseases …
over 43 million blindness. However, efficient drug delivery to treat ocular diseases …
Polymer-and Lipid-Based Nanocarriers for Ocular Drug Delivery: Current Status and Future Perspectives.
H Han, S Li, M Xu, Y Zhong, W Fan, J Xu… - Advanced Drug …, 2023 - europepmc.org
Ocular diseases seriously affect patients' vision and life quality, with a global morbidity of
over 43 million blindness. However, efficient drug delivery to treat ocular diseases …
over 43 million blindness. However, efficient drug delivery to treat ocular diseases …
[PDF][PDF] Polymer-and lipid-based nanocarriers for ocular drug delivery: Current status and future perspectives
H Han, S Li, M Xu, Y Zhong, W Fan, J Xu… - Advanced Drug …, 2023 - researchgate.net
abstract Ocular diseases seriously affect patients' vision and life quality, with a global
morbidity of over 43 million blindness. However, efficient drug delivery to treat ocular …
morbidity of over 43 million blindness. However, efficient drug delivery to treat ocular …
Polymer-and Lipid-Based Nanocarriers for Ocular Drug Delivery: Current Status and Future Perspectives
H Han, S Li, M Xu, Y Zhong, W Fan, J Xu… - Advanced drug … - pubmed.ncbi.nlm.nih.gov
Ocular diseases seriously affect patients' vision and life quality, with a global morbidity of
over 43 million blindness. However, efficient drug delivery to treat ocular diseases …
over 43 million blindness. However, efficient drug delivery to treat ocular diseases …